Literature DB >> 2383059

Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.

P A Reilly1, J A Cosh, P J Maddison, J J Rasker, A J Silman.   

Abstract

One hundred patients with classical (52) or definite (48) rheumatoid arthritis (RA) at one year after onset were followed up for 25 years. By then 63 had died, in one third of whom RA had either directly caused or contributed to death. These patients, at one year after onset of arthritis, had a higher proportion with classical RA and more functional impairment than the rest. Thirty five of the surviving 37 patients were seen for review. Eleven were well with no functional impairment. At one year after onset they had a lower erythrocyte sedimentation rate (ESR) and higher haemoglobin than the others, in whom a poorer outcome was associated with a persistently raised ESR and lower haemoglobin. The initial Rose-Waaler titre was a poor prognostic guide, but a better functional outcome was associated with conversion to seronegativity or a marked fall in rheumatoid factor level.

Entities:  

Mesh:

Year:  1990        PMID: 2383059      PMCID: PMC1004101          DOI: 10.1136/ard.49.6.363

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  29 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Recent trends in rheumatoid arthritis.

Authors:  A J Silman
Journal:  Br J Rheumatol       Date:  1986-11

3.  Survivorship and death in rheumatoid arthritis.

Authors:  J Uddin; A S Kraus; H G Kelly
Journal:  Arthritis Rheum       Date:  1970 Mar-Apr

4.  Infection in rheumatoid arthritis.

Authors:  J Baum
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

5.  Survival and death in rheumatoid arthritis.

Authors:  J A Cosh
Journal:  J Rheumatol       Date:  1984-04       Impact factor: 4.666

6.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

7.  Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study.

Authors:  A Cats; H M Hazevoet
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

8.  Long-term outcome of treating rheumatoid arthritis: results after 20 years.

Authors:  D L Scott; D P Symmons; B L Coulton; A J Popert
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

9.  Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients.

Authors:  S L Feigenbaum; A T Masi; S B Kaplan
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

10.  Survival, prognosis, and causes of death in rheumatoid arthritis.

Authors:  D M Mitchell; P W Spitz; D Y Young; D A Bloch; D J McShane; J F Fries
Journal:  Arthritis Rheum       Date:  1986-06
View more
  30 in total

Review 1.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

Review 2.  Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s.

Authors:  E D Harris
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

3.  Dyslipidemia and rheumatoid arthritis.

Authors:  R D Situnayake; G Kitas
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

4.  Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis.

Authors:  Takeshi Kuroda; Naohito Tanabe; Daisuke Kobayashi; Hiroe Sato; Yoko Wada; Shuichi Murakami; Minoru Sakatsume; Masaaki Nakano; Ichiei Narita
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

5.  Outcome of cervical spine surgery in patients with rheumatoid arthritis.

Authors:  K M van Asselt; W F Lems; E B Bongartz; H L Hamburger; K W Drossaers-Bakker; B A Dijkmans; R M van Soesbergen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 6.  Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins.

Authors:  Radjesh J Bisoendial; Erik S G Stroes; John J P Kastelein; Paul Peter Tak
Journal:  Nat Rev Rheumatol       Date:  2010-02-09       Impact factor: 20.543

Review 7.  Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis.

Authors:  C Barbadillo; A G-Arroyo; C Salas; J Mulero; F Sánchez-Madrid; J L Andreu
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

9.  Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study.

Authors:  C Turesson; A Jarenros; L Jacobsson
Journal:  Ann Rheum Dis       Date:  2004-03-29       Impact factor: 19.103

10.  Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.

Authors:  Tracey E Toms; Vasileios F Panoulas; Holly John; Karen M J Douglas; George D Kitas
Journal:  Arthritis Res Ther       Date:  2009-07-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.